Trial Profile
Pilot Study on Incretin Effect on the Immunological Phenotype in Healthy Subjects and in Type 1 Diabetic Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Saxagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 16 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to to ClinicalTrials.gov record.
- 11 Feb 2013 New source identified: ClinicalTrials.gov record.